Back to search

Article

Optimal COVID-19 Therapeutic Candidate Discovery Using the CANDO Platform

2022-04-26

Abstract excerpt

The worldwide outbreak of SARS-CoV-2 in early 2020 caused numer- ous deaths and unprecedented measures to control its spread. We employed our Computational Analysis of Novel Drug Opportunities (CANDO) multiscale therapeutic discovery, repurposing, and design platform to identify small molecule inhibitors of the virus to treat its resulting indication, COVID-19. Initially, few experimental studies existed on SARS-C...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
17b0325e-3c6e-5383-b95e-8b1a2f4d1e41
DOI
10.20944/preprints202204.0224.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Optimal COVID-19 Therapeutic Candidate Discovery Using the CANDO PlatformDOI 10.20944/preprints202204.0224.v1
Select a neighboring publication to make it the new centre.